Greenville Utilities Commission wins APPA Safety Award
GREENVILLE, N.C. (WNCT) — The American Public Power Association (APPA) recently gave the Greenville Utilities Commission (GUC) a major award.
GUC was given the APPA Safety Award of Excellence for ensuring safe practices happen within their electrical services. Diamond level is the highest recognition that can be received from APPA and GUC earned it by only having two recordable injuries within 275,830 hours worked by 145 employees. Only one of those injuries resulted in a loss of work, totaling five days.
'Our employees have worked hard for many years now to build a safety culture where everyone is keeping an eye on one another and speak up if they see something unsafe,' said GUC Director of Electric John Worrell. 'It's very rewarding when national organizations such as APPA recognize those efforts, and it reinforces the fact that our safety programs are making a difference.'
The GUC started using their Situational Leadership Model in 2022 to train their employees, leading to their seriousness of safety.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 days ago
- Business Wire
Elion Launches Integration of Coalition for Health AI ‘Nutrition Label' Within Vendor Marketplace
NEW YORK--(BUSINESS WIRE)--Elion, the healthcare technology research and intelligence platform for the AI era, announced today a new partnership with the Coalition for Health AI (CHAI), an industry-led coalition committed to developing industry best practices and frameworks to further innovation, safety and security for health AI. As part of this partnership, Elion is beta-launching a new feature: Abridged CHAI model cards now appear on select vendor profiles across its platform. 'As demand for AI adoption accelerates, healthcare leaders need a shared language and set of standards to evaluate solutions responsibly." To facilitate robust evaluation and accelerate adoption of successful AI solutions, CHAI developed an Applied Model Card framework, and recently established its first Model Card registry to support the rapid growth of model cards, or 'nutrition labels' for health AI, used to simplify procurement among health systems and solution providers. CHAI's model cards have created a more standard way to present foundational information about AI solutions, moving from powerpoint presentations to evidence and value-based procurement. Elion cofounder and CEO, Bobby Guelich, announced this new functionality at the CHAI Innovation Summit this week. Providing availability of CHAI's Model Cards through the Elion platform helps provider organizations quickly assess an AI model's intended use, oversight processes, and key performance considerations—all in the context of Elion's broader research and marketplace infrastructure. 'As demand for AI adoption accelerates, healthcare leaders need a shared language and set of standards to evaluate solutions responsibly,' said Guelich. 'CHAI's work in this area is foundational, and we're excited to bring their model cards into the day-to-day workflows of technology decision-makers through Elion's marketplace.' This integration represents the latest step in Elion's mission to equip health systems with the data, tools, and guidance needed to evaluate and implement emerging technologies. The current version includes model cards for a limited set of vendor solutions, with broader availability planned later this year. 'I am thrilled to see our health AI nutrition label advancing effective and responsible health AI,' said Brian Anderson, CHAI's CEO. 'By integrating this with Elion, we are enabling health system AI solution evaluation and allowing decision-makers to easily access Model Cards. CHAI is driven by the expertise of our members and the feedback of our broader health ecosystem and the public. We look forward to working together to unlock the potential benefits of AI, on a foundation of trust, safety, and security." CHAI model cards were designed to enhance transparency and accountability across the AI lifecycle. By displaying key elements of these cards on vendor profiles, Elion aims to bridge the gap between technical documentation and real-world procurement. Learn more about CHAI model cards here. About Elion: Elion is a trusted health IT marketplace and research firm dedicated to empowering healthcare organizations through technology insights and strategic guidance. By bridging the gap between healthcare leaders and innovative solutions, Elion is driving the future of healthcare delivery. For more information, visit: About CHAI: The CHAI (Coalition for Health AI) mission is to be the trusted source of guidelines for Responsible AI in Health. It aims to ensure high-quality care, foster trust among users, and meet the growing healthcare needs. As a coalition bringing together leaders and experts representing health systems, startups, government and patient advocates, CHAI has established working groups focusing on privacy and security, fairness, transparency, usefulness, and safety of AI algorithms.
Miami Herald
4 days ago
- Miami Herald
Tesla execs question Elon Musk over controversial X post
Tesla CEO Elon Musk loved Twitter long before he purchased it. Musk has been a frequent poster on the social media network for years, often sharing his thoughts on everything from the mundane to the profane. He's also gotten himself and Tesla into trouble on the social media platform in the past. Related: Elon Musk fulfills a promise he recently made to Tesla investors Back on August 7, 2018, Musk tweeted, "Am considering taking Tesla private at $420. Funding secured." This tweet led to a class action lawsuit filed by Tesla shareholders, who claimed it was misleading. They claimed it caused them to lose money after stock prices rose nearly 23% in the subsequent days to meet the $420 level, only to decline again once it became clear Musk was not serious about taking the company private. The plaintiffs argued that no one, not even one of the world's wealthiest people, should be above the law, and knowingly misleading shareholders to believe you are taking a company private when you are not is illegal. Musk's defense, meanwhile, argued that while the "funding secured" tweet was only "technically inaccurate" and that "the whole case is built on bad word choice. Who cares about bad word choice?" A San Francisco jury eventually ruled that Musk and Tesla were not liable for misleading investors, letting Musk off the hook after just two hours of deliberation. Six years later, Musk once again found himself in hot water over a tweet, but this time the pressure was coming from inside his company. Image source: NurPhoto/Getty Images Last year, Reuters began reporting on Tesla's plan to discontinue plans for a $25,000 EV that would be the most affordable the company has ever built. When it was first announced, analysts and investors expected the vehicle to be a smashing success like the Model 3, Tesla's current budget option. But, according to three sources who talked to Reuters, Tesla held a meeting attended by scores of employees and told them of the decision not to pursue the model. Elon Musk's reaction to the piece was immediate. "Reuters is lying," Musk said on X after the story was published on April 5. Musk's tweet stopped a 6% slide that day, as the budget model, known as Model 2, had been the linchpin of the company's growth plans. Related: Elon Musk explains DOGE mission, takes shot at government But according to new Reuters reporting, Tesla executives were confused and alarmed by the tweet because the company had, in fact, decided to abandon the Model 2. They felt Musk's tweet could potentially make them financially liable, like his tweet in 2018 almost did. Some senior managers were so confused by the tweet that they asked Musk whether he had changed his mind about the car. Musk assured them that the project was still off. The company had previously said that the Model 2 would be an all-new model, built and designed from scratch, that would revamp Tesla's entire image. Instead, the company plans to offer slimmed-down versions of its popular Model 3 sedan and Model Y SUV. No prices have been set for those models, and their expected rollout in the first half of 2025 has been delayed. One Tesla executive said that some other Tesla execs weren't as concerned about the tweet because the company's product plans remain flexible. However, one of the biggest concerns some execs had was about the Securities and Exchange Commission. While Musk was able to win the jury trial back in 2018, he could not escape the SEC. Musk settled claims over the funding secured tweet, with the agency alleging that Musk misled investors by saying he was planning to take Tesla private. As part of the settlement, Musk agreed to step down as chairman of Tesla, pay a $20 million fine (with Tesla also paying another $20 million), and add two new independent directors to his board. Musk also agreed to have his social media posts about Tesla be vetted by a lawyer. Reuters reported that some of the executives questioning Musk told associates that they feared Musk's tweet could have violated his settlement with the SEC because he was misleading investors about a future product they had already agreed to scrap. The SEC did not immediately return a request for comment. Related: Elon Musk says he is 'paranoid' about this issue; he's right to be The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
30-05-2025
- Yahoo
DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates
DENVER, May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek, chief transformation officer for DaVita. "As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices (KCC) Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emphasis on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes. DaVita is committed to establishing a new standard for kidney care through integrated care systems alongside our nephrology partners." Together with participating nephrologists, DaVita launched 11 value-based care arrangements in 2022 and has since doubled that footprint to 22 Kidney Contracting Entities (KCEs). A recent report demonstrates that these value-based care arrangements result in increased transplantation, more patients dialyzing with an optimal access in place, and more patients dialyzing at home. To learn more about DaVita Integrated Kidney Care programs, visit About DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2025, DaVita served approximately 282,000 patients at 3,173 outpatient dialysis centers, of which 2,661 centers were located in the United States and 512 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit Media Contact Newsroom@ View original content: SOURCE DaVita Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
